Latest Breaking News On - System atrophy - Page 23 : comparemela.com

Publication in Presents to MST Access Australian Micro & Small Caps Conference Cash balance at 30 June 2021 of A$28M MELBOURNE, Australia, July 30, 2021 /PRNewswire/ Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ( Alterity or the Company ), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2021 (Q4 FY21). The Company’s cash position at 30 June 2021 of $28M was bolstered by the receipt of $17M in net proceeds from the use of the company’s previously approved At the Market facility with shares issued in accordance with ASX Listing Rules 7.1 and 7.1A.

United statesSan franciscoDavid stamlerMovement disordersCompany phaseVanderbilt university medical centerMovement disorder societyDrug administrationEuropean unionEuropean medicines agencyInternational parkinsonAlterity therapeutics limitedAlterity therapeuticsPublication in movement disordersAustralian microSmall caps conference